Navigation Links
Tobira Therapeutics Inc. Receives US Patent for TBR-652
Date:8/18/2008

- Clinical trial currently in Phase I -

PRINCETON, N.J. and SAN DIEGO, Aug. 18 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the issuance of Patent No. 7,371,772 B2 by the U.S. Patent and Trademark Office, covering the use of TBR-652, a CCR5 antagonist currently in Phase I development for the treatment of HIV-1 infection in adults.

This patent is part of Tobira's growing portfolio of medicines to treat infectious diseases. In addition, they were recently issued European Patent No. 1,220,842 for TBR-220, a second CCR5 antagonist for the treatment of HIV/AIDS and have an additional patent pending. In response to this news, James Sapirstein, Chief Executive Officer of Tobira Therapeutics noted, "It is gratifying to progress the intellectual property of these compounds and look forward to future clinical trial results."

About Tobira Therapeutics, Inc.

Tobira Therapeutics is a private biopharmaceutical company which is focused on developing and commercializing innovative antiviral compounds to treat HIV disease. The company was founded in 2006 by Eckard Weber, MD, a partner at the venture capital firm Domain Associates, to develop novel treatments for HIV disease. Tobira has assembled a highly experienced management team with decades of clinical and commercial development experience specifically in HIV/AIDS drug development.

Contact:

Tobira Therapeutics, Inc.

James Sapirstein CEO and President Tobira Therapeutics, Inc.

jsapirstein@tobiratherapeutics.com

Tel: 609-897-1102

http://www.tobiratherapeutics.com


'/>"/>
SOURCE Tobira Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
2. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
3. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
4. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
5. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
6. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
7. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
8. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
9. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
10. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nas...foraorticdisorders,announcedtodaythatithasfiledamo...infringementlawsuitbroughtagainstitinOctober2009by...tCourtinIndianapolis,Indiana. ,, Endologixhasre...esPatentandTrademarkOffice(USPTO)conductsproceedin...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--AnadysPharmaceuticals,I...tthe21stAnnualPiperJaffrayHealthcareConferenceonTu...conferenceisbeingheldatTheNewYorkPalaceHotel.Steve...nadys,willprovideanoverviewofAnadysanditsclinicald...ratepresentationwillbesimultaneouslywebcastandcanb...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--ThoratecCorpor...hanicalcirculatorysupporttherapiestosave,supportan...patinginthe21stAnnualPiperJaffrayHealthCareConfere...vevicepresidentandchieffinancialofficer,willprovid...tandardTime(5:30a.m.,PacificStandardTime). ,, T...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac an Animal Free Reagent for Bacterial Fermentation 61073 1InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac an Animal Free Reagent for Bacterial Fermentation 61073 2Wounded Warrior Project Urges the Senate to Support Crucial Family Caregiver Legislation 61070 1Wounded Warrior Project Urges the Senate to Support Crucial Family Caregiver Legislation 61070 2Reportlinker Adds Cancer Non Hodgkin Lymphoma 61067 1Reportlinker Adds Cancer Non Hodgkin Lymphoma 61067 2
(Date:11/26/2009)...onal rollercoaster, study finds , , THUR... factor meets the jubilant sports fan. , A new ... who root for the winning team -- enjoy the greate...and victory was in doubt, producing feelings of wo...sgiving weekend as you,re glued to the TV set, wat...
(Date:11/26/2009)...is, P.A. is offering free nationwide confidential ...ntrol pills who have suffered a Deep Vein Thrombos... or other related cardiac issues or had their Gall...-856-6405 or go to the firm’s website at ht... evaluation form. , (PRWE...
(Date:11/25/2009)...elleMedicalInc.,aleadingmanufacturerofbreastMRIcoi...newleadingedgeclinicalapplicationsonitsAegis(TM)me...alSocietyofNorthAmerica(RSNA)annualmeetinginChicag...nsleveragetheuniquehighqualityimagesgeneratedbySen...pleimagingmodalitiesformulti-parametricassessment....
(Date:11/25/2009)...ess,andPressJoinEfforttoEducate ,, MEMPHIS,Ten...ionalBipolarFoundationandtheMedicAlertFoundationre...ogram,whichisnowbeingwidelyacceptedasapreventivehe...lBipolarFoundationreceivedaproclamationofendorseme...fLouisianaMitchLandrieu.TheNationalBipolarFoundati...
(Date:11/25/2009)...to draw definite conclusions, experts say, , ...diabetic patients with blocked coronary arteries, ...ne year whether patients undergo bypass surgery or...port. , Bypass surgery has been the standard tr... disease. However, less invasive approaches such a...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ditions related to chronic kidney disease are inde...ar disease; conversely , heart disease is associat...opment of kidney disease, according to two reports...according to background information in the article...
...of doctors using advertisements to lure patients t...nt Monday asked the state's medical council to tak...b's medical education and research minister Tiksha...The prime object of the medical profession is to s...
...re developing a flu vaccine that will give lifelon...ight anything from winter flu to bird flu . ...ne is easier to make and can also be stocked for a...binson of the Buckinghamshire company PepTcell, wh...
...nited Kingdom have found that patients with COPD, ...ater arterial stiffness. The researchers also fou...ommon complication of the respiratory disease, had... Their research results appear in the second issue...
...s have identified common DNA variations that under...tion. Most of the eight genetic alterations the sc...ever after smallpox vaccination. A few, however, r...nfluence fever risk after other live-virus vaccine...
...am of Emory University scientists have found a no...genetic mutations recently identified in Parkinson...the mutations affect cellular function and could ...om the loss of neurons in the brain that produce d...
Other Medicine News:Health News:Studies Identify Interactions Between Heart Disease, Kidney Disease 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 3Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Parkinsons Disease Protein Pathway Identified 2
Vari-I-Stat, 454-649C (849-1200F), 1/2" shaft with fine tip
Accu-Temp Fixed, 1205C (2200F), 2" shaft with loop tip
Accu-Temp Fixed, 1205C (2200F), 1/2" shaft with fine tip
...ry LASIK Light Probes provide the surgeon with an ...al interface to be easily visualized through the l...and light scatter technique, the surgeon can enhan...eposits, flap edge folds, corneal flap striae and ...
Medicine Products: